Next earnings date: 15 Oct 2025
Intuitive Surgical, Inc. β NASDAQ:ISRG
Intuitive Surgical stock price today
Intuitive Surgical stock price monthly change
Intuitive Surgical stock price quarterly change
Intuitive Surgical stock price yearly change
Intuitive Surgical key metrics
Market Cap | 185.59B |
Enterprise value | N/A |
P/E | 71.4 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 14.82 |
Price/Book | 8.30 |
PEG ratio | -3.02 |
EPS | 5.64 |
Revenue | 7.31B |
EBITDA | 2.18B |
Income | 1.98B |
Revenue Q/Q | 11.46% |
Revenue Y/Y | 13.80% |
Profit margin | 21.25% |
Oper. margin | 25.35% |
Gross margin | 67.44% |
EBIT margin | 25.35% |
EBITDA margin | 29.92% |
create your own Smart Feed
Personalize your watchlist with companies you want toΒ keep trackΒ of and getΒ notified inΒ theΒ smart feed every time fresh news arrives.
Sign up for freeIntuitive Surgical stock price history
Intuitive Surgical stock forecast
Intuitive Surgical financial statements
$547.88
Potential upside: 13.56%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 1.75B | 420.8M | 23.96% |
|---|---|---|---|
| Sep 2023 | 1.74B | 415.7M | 23.84% |
| Dec 2023 | 1.92B | 606.2M | 31.44% |
| Mar 2024 | 1.89B | 544.9M | 28.82% |
| 2024-10-17 | 1.63 | 1.84 |
|---|
| Jun 2023 | 13903300000 | 1.94B | 13.98% |
|---|---|---|---|
| Sep 2023 | 14712700000 | 2.08B | 14.2% |
| Dec 2023 | 15441500000 | 2.04B | 13.24% |
| Mar 2024 | 15828000000 | 1.78B | 11.26% |
| Jun 2023 | 665.7M | 557.6M | 63.3M |
|---|---|---|---|
| Sep 2023 | 548.4M | -446.6M | 61.8M |
| Dec 2023 | 228.3M | -1.04B | -31.5M |
| Mar 2024 | 38.8M | -128.5M | 179.9M |
Intuitive Surgical alternative data
Intuitive Surgical
| 5 Feb 2023 | 28 |
|---|---|
| 12 Feb 2023 | 32 |
| 19 Feb 2023 | 51 |
| 26 Feb 2023 | 40 |
| 5 Mar 2023 | 42 |
| 12 Mar 2023 | 42 |
| 19 Mar 2023 | 29 |
| 26 Mar 2023 | 31 |
| 2 Apr 2023 | 57 |
| 9 Apr 2023 | 33 |
| 16 Apr 2023 | 29 |
| 23 Apr 2023 | 34 |
| 30 Apr 2023 | 33 |
| 7 May 2023 | 35 |
| 14 May 2023 | 36 |
| 21 May 2023 | 37 |
| 28 May 2023 | 33 |
| 4 Jun 2023 | 34 |
| 11 Jun 2023 | 32 |
| 18 Jun 2023 | 31 |
Intuitive Surgical Products & Services
| 21 May 2023 | 0 | 0 |
|---|---|---|
| 28 May 2023 | 0 | 0 |
| 4 Jun 2023 | 0 | 0 |
| 11 Jun 2023 | 0 | 0 |
| 18 Jun 2023 | 0 | 0 |
| 25 Jun 2023 | 0 | 0 |
| 2 Jul 2023 | 0 | 0 |
| 9 Jul 2023 | 0 | 0 |
| 16 Jul 2023 | 0 | 0 |
| 23 Jul 2023 | 0 | 0 |
| 30 Jul 2023 | 0 | 0 |
| 6 Aug 2023 | 0 | 0 |
| 13 Aug 2023 | 0 | 0 |
| 20 Aug 2023 | 0 | 0 |
| 27 Aug 2023 | 0 | 0 |
| 3 Sep 2023 | 0 | 0 |
| 10 Sep 2023 | 0 | 0 |
| 17 Sep 2023 | 0 | 0 |
| 24 Sep 2023 | 0 | 0 |
| 1 Oct 2023 | 0 | 0 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
| Sep 2023 | 335 |
|---|---|
| Oct 2023 | 298 |
| Nov 2023 | 298 |
| Dec 2023 | 290 |
| Jan 2024 | 374 |
| Feb 2024 | 455 |
| Jan 2025 | 342 |
| Sep 2023 | 12,120 |
|---|---|
| Oct 2023 | 12,120 |
| Nov 2023 | 12,120 |
| Dec 2023 | 12,120 |
| Jan 2024 | 12,120 |
| Feb 2024 | 13,676 |
| Mar 2024 | 13,676 |
| Apr 2024 | 13,676 |
| May 2024 | 13,676 |
| Jun 2024 | 13,676 |
| Jul 2024 | 13,676 |
Intuitive Surgical other data
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 18236 |
| Apr 2024 | 0 | 5272 |
| May 2024 | 0 | 5253 |
| Oct 2024 | 0 | 30934 |
| Nov 2024 | 0 | 27835 |
| Dec 2024 | 0 | 135 |
| Quarter | Transcript |
|---|---|
| Q1 2024 18 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q1 2023 18 Mar 2024 | Q1 2023 Earnings Call Transcript |
| Q4 2023 23 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 19 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Gary S. Guthart (1966) Pres, Chief Executive Officer & Director | $822,980 |
| Mr. David J. Rosa (1968) Executive Vice President and Chief Strategy & Growth Officer | $591,470 |
| Mr. Marshall L. Mohr (1956) Executive Vice President of Global Bus. Services | $567,750 |
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. (1957) Executive Vice President & Chief Medical Officer | $566,380 |
| Mr. Robert DeSantis (1966) Executive Vice President & Chief Product Officer | $532,550 |
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade)
SS Innovations: A Speculative Bet On Robotic Surgeries
Intuitive Surgical: More Than Robots - Why Its AI-Powered Platform Deserves A Premium
Boston Scientific: Old, Reliable; Buy For Their Consistent Growth
Intuitive Surgical: Moat, Resilience But High Market Expectations
Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook
Stock Picks From Seeking Alpha's April 2025 New Analysts
-
What's the price of Intuitive Surgical stock today?
One share of Intuitive Surgical stock can currently be purchased for approximately $482.42.
-
When is Intuitive Surgical's next earnings date?
Intuitive Surgical, Inc. is estimated to report earnings on Wednesday, 15 Oct 2025.
-
Does Intuitive Surgical pay dividends?
No, Intuitive Surgical does not pay dividends.
-
How much money does Intuitive Surgical make?
Intuitive Surgical has a market capitalization of 185.59B and it's past yearsβ income statements indicate that its last revenue has increased compared to the previous period by 14.49% to 7.12B US dollars. Intuitive Surgical earned 1.8B US dollars in net income (profit) last year or $1.84 on an earnings per share basis.
-
What is Intuitive Surgical's stock symbol?
Intuitive Surgical, Inc. is traded on the NASDAQ under the ticker symbol "ISRG".
-
What is Intuitive Surgical's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Intuitive Surgical?
Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the following people:
- Dr. Gary S. Guthart Pres, Chief Executive Officer & Director(age: 59, pay: $822,980)
- Mr. David J. Rosa Executive Vice President and Chief Strategy & Growth Officer(age: 57, pay: $591,470)
- Mr. Marshall L. Mohr Executive Vice President of Global Bus. Services(age: 69, pay: $567,750)
- Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Executive Vice President & Chief Medical Officer(age: 68, pay: $566,380)
- Mr. Robert DeSantis Executive Vice President & Chief Product Officer(age: 59, pay: $532,550)
-
How many employees does Intuitive Surgical have?
As Jul 2024, Intuitive Surgical employs 13,676 workers.
-
When Intuitive Surgical went public?
Intuitive Surgical, Inc. is publicly traded company for more then 25 years since IPO on 16 Jun 2000.
-
What is Intuitive Surgical's official website?
The official website for Intuitive Surgical is intuitive.com.
-
Where are Intuitive Surgical's headquarters?
Intuitive Surgical is headquartered at 1020 Kifer Road, Sunnyvale, CA.
-
How can i contact Intuitive Surgical?
Intuitive Surgical's mailing address is 1020 Kifer Road, Sunnyvale, CA and company can be reached via phone at +40 85232100.
-
What is Intuitive Surgical stock forecast & price target?
Based on 12 Wall Street analysts` predicted price targets for Intuitive Surgical in the last 12 months, the avarage price target is $547.88. The average price target represents a 13.56% change from the last price of $482.42.
Intuitive Surgical company profile:
Intuitive Surgical, Inc.
intuitive.comNASDAQ
13,676
Medical - Instruments & Supplies
Healthcare
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Sunnyvale, CA 94086-5304
CIK: 0001035267
ISIN: US46120E6023
CUSIP: 46120E602







